Every class of psychoactive drug produces a distinct short-term fingerprint on the body and mind, shaped by its mechanism of action, the dose taken, and the person taking it. Stimulants raise heart rate and sharpen focus; depressants slow the brain’s signaling and relax muscles; opioids dull pain while suppressing breathing; psychedelics scramble normal sensory processing. But those broad strokes hide important detail, because no two drug classes act on the same brain systems in the same way, and factors like how a drug is consumed, what else is in the body, and even biological sex can change the experience dramatically.
Stimulants
Stimulants include drugs like amphetamine, cocaine, methamphetamine, and prescription medications such as methylphenidate. They work primarily by flooding the brain with dopamine and norepinephrine, which produces a burst of energy, heightened alertness, euphoria, and reduced appetite. The cardiovascular effects are immediate and measurable: methylphenidate, for instance, significantly increases heart rate and both systolic and diastolic blood pressure, and those blood-pressure spikes correlate directly with how much dopamine the drug releases in the brain and how much epinephrine rises in the bloodstream.1PubMed. Cardiovascular effects of methylphenidate in humans are associated with increases of dopamine in brain and of epinephrine in plasma People who showed no dopamine increase in that study also showed no rise in blood pressure, which underscores how tightly the cardiovascular punch of a stimulant is linked to its brain activity.
At higher doses or with more potent stimulants like cocaine or methamphetamine, those same effects intensify. Pupils dilate, body temperature rises, and the heart can beat dangerously fast. Subjectively, users report feeling confident, talkative, and physically restless. The crash that follows a stimulant high often brings fatigue, irritability, and low mood as dopamine stores are temporarily depleted.
MDMA and Temperature
MDMA (ecstasy) sits in a middle ground between stimulants and psychedelics. It releases large amounts of serotonin alongside norepinephrine and dopamine, which creates a distinctive cocktail of euphoria, emotional openness, and sensory enhancement. One of its most dangerous short-term effects is hyperthermia. Research in humans supports the conclusion that MDMA mainly increases body temperature through norepinephrine release, which ramps up metabolic heat production while impairing the body’s ability to shed that heat by constricting blood vessels near the skin. Serotonin release likely contributes as well.2PubMed Central. Effects of MDMA on body temperature in humans In hot, crowded environments like clubs or festivals, this effect can escalate to heat stroke.
Depressants and Alcohol
Depressants, which include alcohol, benzodiazepines (like diazepam and alprazolam), and barbiturates, work by enhancing the brain’s main inhibitory signaling system. Alcohol, for example, acts as a booster on GABA-A receptors, binding to specific subunits and amplifying the brain’s natural “slow down” signals. That mechanism explains its sedative and muscle-relaxing properties.3Frontiers in Neural Circuits. GABAergic signaling in alcohol use disorder and withdrawal: pathological involvement and therapeutic potential
In practical terms, short-term depressant effects start with reduced anxiety, lowered inhibitions, and a sense of relaxation. As the dose rises, coordination deteriorates, speech slurs, reaction time lengthens, and judgment worsens. At high doses, depressants can suppress breathing and consciousness enough to be fatal. Benzodiazepines tend to produce these effects in a more targeted way than alcohol, partly because they act on a more specific subset of GABA receptors. When alcohol and benzodiazepines are combined, the interaction worsens both reaction time and divided attention in a way that depends on the dose and timing of each substance.4PubMed. The Combined Effects of Alcohol and Benzodiazepines on Driving-Related Neurocognitive Skills: A Systematic Review
Opioids
Opioids, both prescription painkillers like oxycodone and illicit drugs like heroin and fentanyl, bind to the brain’s mu-opioid receptors. The immediate effect is powerful pain relief, accompanied by a warm, drowsy euphoria, nausea (especially in new users), and constricted pupils. The most dangerous short-term effect is respiratory depression: opioids directly inhibit the rhythm-generating neurons in the brainstem that keep you breathing.5PubMed. 5-HT4(a) receptors avert opioid-induced breathing depression without loss of analgesia This is why opioid overdoses are so lethal and why the antidote naloxone, which competitively displaces opioids from those receptors, can be lifesaving.6PubMed Central. Flumazenil, naloxone and the ‘coma cocktail’
Constipation, itching, and dry mouth are near-universal short-term side effects even at therapeutic doses. With street-sourced opioids, users face the additional risk that the actual dose is unpredictable, especially with illicitly manufactured fentanyl, which is active at microgram quantities.
Cannabis
Cannabis produces short-term effects primarily through THC binding to cannabinoid receptors concentrated in the brain’s cortex, hippocampus, and cerebellum. The result is a mix of relaxation, altered time perception, heightened sensory experience, and impaired short-term memory. In controlled studies, marijuana increased heart rate and slowed responses on working-memory tasks, with participants becoming both slower and less accurate after smoking.7PubMed Central. Effects of marijuana on neurophysiological signals of working and episodic memory
How cannabis is consumed changes the experience considerably. Inhaled cannabis produces effects within minutes, while edibles can take an hour or more, which frequently leads to accidental overconsumption. A toxicology review of acute cannabis exposures found striking age-related differences: children who accidentally ingested edibles primarily experienced sedation, while adults who intentionally consumed cannabis more often showed neuroexcitation, such as anxiety and agitation. Across all ages, inhaled cannabis was more likely to cause a racing heart and agitation than ingested forms.8Taylor & Francis Online (Clinical Toxicology). Acute cannabis toxicity
Psychedelics
Classic psychedelics like LSD and psilocybin act mainly on serotonin 2A receptors in the cortex. The hallmark short-term effects are visual distortions, synesthesia, altered sense of self, and intense emotional shifts that can range from profound awe to acute fear. On a physical level, LSD significantly increases blood pressure, heart rate, body temperature, and pupil size, along with raising stress hormones like cortisol and epinephrine.9PubMed. Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects
Brain imaging studies reveal what is happening under the hood. LSD decreases connectivity within several brain networks, including visual, sensorimotor, auditory, and the default mode network, which is the system active during mind-wandering and self-referential thought.10PubMed Central. Altered network hub connectivity after acute LSD administration The disruption of normal network boundaries is thought to be why psychedelic experiences feel so unfamiliar and why everyday mental categories seem to dissolve. These effects are dose-dependent and time-limited, typically lasting six to twelve hours for LSD and four to six hours for psilocybin.
Dissociatives and Inhalants
Dissociative drugs like ketamine and PCP produce a distinctive state of detachment from the body and surroundings. Ketamine works by blocking NMDA receptors, a type of glutamate receptor involved in consciousness and sensory processing. This mechanism generates a rapid-onset anesthetic effect and, unlike traditional anesthetics, creates a dissociative state of altered awareness rather than simple unconsciousness. At sub-anesthetic doses, the same receptor blockade produces rapid antidepressant effects, which is why ketamine has gained attention as a psychiatric treatment.11PubMed Central. The role of NMDARs in the anesthetic and antidepressant effects of ketamine Short-term physical effects include raised blood pressure, nausea, and impaired coordination. At higher recreational doses, users can enter a “k-hole,” a state of near-total dissociation that can feel paralyzing.
Inhalants, which include volatile solvents, aerosol propellants, and gases, are a separate category with uniquely immediate dangers. Their high comes from central nervous system depression and lasts only minutes, but the cardiac risk is disproportionate to that brief window. Inhaled hydrocarbons sensitize heart muscle cells, and when the body releases a surge of adrenaline (from excitement, exertion, or being startled), that sensitization can trigger fatal cardiac arrhythmias.12PubMed Central. Rare but relevant: Hydrocarbons and sudden sniffing syndrome This mechanism, sometimes called “sudden sniffing death,” has been documented since the early 1970s, when experimental investigation confirmed that common aerosol propellants in high concentrations sensitize the heart to epinephrine-driven arrhythmias.13Archives of Environmental & Occupational Health. Cardiac arrhythmias and aerosol “sniffing” It can happen on a first use.
Why the Route of Use Matters
The same drug can feel substantially different depending on how you take it. A drug that is smoked or injected reaches the brain in seconds, producing a sharp, intense peak. Swallowed, that same drug is absorbed gradually through the gut, producing a slower, flatter curve. This is not just a matter of convenience or intensity: the route of administration has a profound influence on the drug experience itself, the risk of developing dependence, and the kinds of health harms a user faces.14PubMed. Route of drug use and its implications for drug effect, risk of dependence and health consequences
Fast-onset routes tend to create a more reinforcing “rush,” which is one reason crack cocaine (smoked) is associated with a faster path to compulsive use than powdered cocaine (snorted). Injection introduces its own set of acute risks, from vein damage and abscesses to blood-borne infections. Snorting damages nasal tissue. These route-specific harms are separate from the pharmacological effects of the drug itself and often get overlooked in conversations about short-term risks.
What Happens When Drugs Are Mixed
Mixing substances does not simply add their effects together. Some combinations create new dangers that neither drug poses alone. The two most common and most studied dangerous combinations involve either cocaine with alcohol or opioids with alcohol.
When cocaine and alcohol are taken together, the liver produces a unique metabolite called cocaethylene. This substance has stimulant properties similar to cocaine but is thought to be more toxic to the heart.15PubMed Central. Cocaethylene: When Cocaine and Alcohol Are Taken Together Animal research has shown that peak cocaethylene levels can dramatically reduce cardiac output and trigger ventricular arrhythmias.16PubMed. Cocaine, ethanol, and cocaethylene cardiotoxity in an animal model of cocaine and ethanol abuse A systematic review found that the presence of cocaethylene carries an 18- to 25-fold increase in the risk of sudden death compared with cocaine alone.17PubMed Central. Cardiovascular Risks of Simultaneous Use of Alcohol and Cocaine-A Systematic Review That is not a small multiplier. Many users combine these two drugs precisely because alcohol softens the jitteriness of cocaine, unaware that the combination is far more dangerous than either substance individually.
Mixing opioids with alcohol is equally treacherous, because both suppress breathing through overlapping mechanisms. Ethanol added to oxycodone caused a further 19% decrease in ventilation beyond what the opioid alone produced.18Anesthesiology. Influence of Ethanol on Oxycodone-induced Respiratory Depression: A Dose-escalating Study in Young and Elderly Individuals With fentanyl, the picture is even grimmer: combining fentanyl with a sedative-level alcohol dose resulted in greater than 40% mortality in an animal model, an effect not seen with either drug alone, and naloxone did not fully reverse the respiratory depression from the combination.19Journal of Clinical Investigation. Potentiation of fentanyl-induced respiratory depression by alcohol is not fully reversed by naloxone That last finding is particularly alarming, because it means the standard overdose rescue medication may not be enough when alcohol is involved.
Sex Differences in Acute Drug Effects
Biological sex changes how drugs hit the body in ways that are often underappreciated. Women generally achieve higher blood alcohol levels than men after drinking the same amount per body weight, partly because of differences in body water composition and enzyme activity. Research has shown that women in the middle phase of the menstrual cycle and women not using hormonal birth control reached consistently higher blood alcohol levels than men given the same dose.20Addictive Behaviors. Gender differences in acute psychomotor, cognitive, and pharmacokinetic response to alcohol
Cannabis follows a similar pattern. In a study comparing oral and vaporized cannabis, women showed higher peak blood levels of a key THC metabolite and reported greater subjective drug effects than men. Even after controlling for body weight and blood cannabinoid concentrations, women rated themselves as more anxious, more restless, and more aware of their heart racing.21PubMed Central. Sex differences in the acute effects of oral and vaporized cannabis among healthy adults For cocaine, animal research points to estradiol as a key driver: female rats with high estradiol levels showed greater cocaine-induced brain activation and locomotion than low-estradiol females, while in males the relationship was reversed.22PubMed Central. The medial preoptic area and acute cocaine’s stimulant effects in rats: Potential influences of estradiol and biological sex These hormonal influences mean that a woman’s short-term response to a given drug dose can shift across her menstrual cycle.
Genetic Variability in Drug Metabolism
Even setting sex aside, two people of the same weight, age, and health status can have vastly different reactions to the same drug because of inherited differences in liver enzymes. The enzyme CYP2D6 is the most extensively studied example. It metabolizes a wide range of psychoactive drugs, including many opioids, antidepressants, and amphetamines. About 7% of people of European descent are “poor metabolizers” who break these drugs down very slowly, which can cause standard doses to build up to dangerous levels. On the other end, “ultrarapid metabolizers” clear drugs so fast that normal doses may barely work. Intermediate metabolizers fall somewhere in between.23PubMed Central. Molecular genetics of CYP2D6: clinical relevance with focus on psychotropic drugs More than 70 genetic variants of this single enzyme have been identified, and the distribution of those variants differs across ethnic populations.
This variability is one reason why “standard doses” are statistical averages, not individual prescriptions. It also helps explain why one person can drink three cups of coffee and feel fine while another is jittery after one, or why a standard codeine dose provides no pain relief for some people (ultrarapid metabolizers actually convert codeine to morphine too fast, creating a different kind of risk).
Set, Setting, and the Placebo Effect
Pharmacology is not the whole story. The psychological context surrounding drug use, sometimes called “set and setting,” shapes what the user actually experiences. “Set” refers to the person’s mindset, expectations, and emotional state going in. “Setting” is the physical and social environment. Research on psychedelics has emphasized that factors like expectancy, preparation, and beliefs are crucial for understanding the processes that shape a drug response beyond the pharmacology itself.24PubMed Central. Set and setting, psychedelics and the placebo response: An extra-pharmacological perspective on psychopharmacology
This principle applies well beyond psychedelics. People who expect alcohol to make them aggressive tend to become more aggressive even when given a placebo drink. People in comfortable environments with trusted friends are less likely to experience anxiety on cannabis than those in unfamiliar or stressful settings. When researchers measure subjective drug effects using standardized questionnaires, participants reliably distinguish drug from placebo across substances like amphetamine, nicotine, and alcohol, reporting stronger feelings of being high, liking the drug, and wanting more. But the magnitude of those ratings varies considerably from person to person, reflecting the interplay between chemistry and context.25PubMed Central. The Drug Effects Questionnaire: Psychometric Support across Three Drug Types
Novel Psychoactive Substances
A growing challenge for anyone trying to understand short-term drug effects is the flood of novel psychoactive substances, often marketed as “legal highs” or “research chemicals.” These are typically divided into four groups: synthetic stimulants (like cathinones, sold as “bath salts”), synthetic cannabinoids (sprayed onto plant material and sold as “spice” or “K2”), synthetic hallucinogens, and synthetic depressants that include designer benzodiazepines and illicit fentanyl analogs.26PubMed Central. New psychoactive substances: a review and updates Each group roughly mimics the short-term effects of its traditional counterpart but often with greater potency, longer duration, or more unpredictable side effects. Synthetic cannabinoids, for instance, bind more strongly and more fully to cannabinoid receptors than THC does, which is why they cause seizures, psychosis, and kidney injury at rates that natural cannabis does not. Because these substances are constantly being reformulated to skirt drug laws, clinical data on any given compound is thin. Users are essentially experimenting on themselves with chemicals that may have no published human safety data at all.